254 related articles for article (PubMed ID: 20394048)
21. Interaction between the cellular prion (PrPC) and the 2P domain K+ channel TREK-1 protein.
Azzalin A; Ferrara V; Arias A; Cerri S; Avella D; Pisu MB; Nano R; Bernocchi G; Ferretti L; Comincini S
Biochem Biophys Res Commun; 2006 Jul; 346(1):108-15. PubMed ID: 16750514
[TBL] [Abstract][Full Text] [Related]
22. The neurochemical nature of PrP(c)-containing cells in the rat brain.
Moleres FJ; Velayos JL
Brain Res; 2007 Oct; 1174():143-51. PubMed ID: 17854776
[TBL] [Abstract][Full Text] [Related]
23. Heterogeneous PrPC metabolism in skeletal muscle cells.
Massimino ML; Ferrari J; Sorgato MC; Bertoli A
FEBS Lett; 2006 Feb; 580(3):878-84. PubMed ID: 16430889
[TBL] [Abstract][Full Text] [Related]
24. Study on the toxic mechanism of prion protein peptide 106-126 in neuronal and non neuronal cells.
Dupiereux I; Zorzi W; Rachidi W; Zorzi D; Pierard O; Lhereux B; Heinen E; Elmoualij B
J Neurosci Res; 2006 Aug; 84(3):637-46. PubMed ID: 16786576
[TBL] [Abstract][Full Text] [Related]
25. Development of oligomeric prion-protein aggregates in a mouse model of prion disease.
Sasaki K; Minaki H; Iwaki T
J Pathol; 2009 Sep; 219(1):123-30. PubMed ID: 19479969
[TBL] [Abstract][Full Text] [Related]
26. Epithelial and endothelial expression of the green fluorescent protein reporter gene under the control of bovine prion protein (PrP) gene regulatory sequences in transgenic mice.
Lemaire-Vieille C; Schulze T; Podevin-Dimster V; Follet J; Bailly Y; Blanquet-Grossard F; Decavel JP; Heinen E; Cesbron JY
Proc Natl Acad Sci U S A; 2000 May; 97(10):5422-7. PubMed ID: 10792029
[TBL] [Abstract][Full Text] [Related]
27. Ultrastructural localization of prion proteins: physiological and pathological implications.
Fournier JG; Escaig-Haye F; Grigoriev V
Microsc Res Tech; 2000 Jul; 50(1):76-88. PubMed ID: 10871551
[TBL] [Abstract][Full Text] [Related]
28. Detection of PrP in extraneural tissues.
Brown KL; Ritchie DL; McBride PA; Bruce ME
Microsc Res Tech; 2000 Jul; 50(1):40-5. PubMed ID: 10871547
[TBL] [Abstract][Full Text] [Related]
29. Expression of prion protein in the gut of mice infected orally with the 301V murine strain of the bovine spongiform encephalopathy agent.
González L; Terry L; Jeffrey M
J Comp Pathol; 2005 May; 132(4):273-82. PubMed ID: 15893985
[TBL] [Abstract][Full Text] [Related]
30. From cell protection to death: may Ca2+ signals explain the chameleonic attributes of the mammalian prion protein?
Sorgato MC; Bertoli A
Biochem Biophys Res Commun; 2009 Feb; 379(2):171-4. PubMed ID: 19101513
[TBL] [Abstract][Full Text] [Related]
31. Cellular prion protein signaling in serotonergic neuronal cells.
Mouillet-Richard S; Schneider B; Pradines E; Pietri M; Ermonval M; Grassi J; Richards JG; Mutel V; Launay JM; Kellermann O
Ann N Y Acad Sci; 2007 Jan; 1096():106-19. PubMed ID: 17405922
[TBL] [Abstract][Full Text] [Related]
32. Towards cellular receptors for prions.
Lee KS; Linden R; Prado MA; Brentani RR; Martins VR
Rev Med Virol; 2003; 13(6):399-408. PubMed ID: 14625887
[TBL] [Abstract][Full Text] [Related]
33. Utility of RNAi-mediated prnp gene silencing in neuroblastoma cells permanently infected by prions: potentials and limitations.
Kim Y; Han B; Titlow W; Mays CE; Kwon M; Ryou C
Antiviral Res; 2009 Nov; 84(2):185-93. PubMed ID: 19748523
[TBL] [Abstract][Full Text] [Related]
34. Prion-protein-specific aptamer reduces PrPSc formation.
Proske D; Gilch S; Wopfner F; Schätzl HM; Winnacker EL; Famulok M
Chembiochem; 2002 Aug; 3(8):717-25. PubMed ID: 12203970
[TBL] [Abstract][Full Text] [Related]
35. The scrapie prion protein is present in flotillin-1-positive vesicles in central- but not peripheral-derived neuronal cell lines.
Pimpinelli F; Lehmann S; Maridonneau-Parini I
Eur J Neurosci; 2005 Apr; 21(8):2063-72. PubMed ID: 15869502
[TBL] [Abstract][Full Text] [Related]
36. Upregulation of cellular prion protein (PrPc) after focal cerebral ischemia and influence of lesion severity.
Weise J; Crome O; Sandau R; Schulz-Schaeffer W; Bähr M; Zerr I
Neurosci Lett; 2004 Nov; 372(1-2):146-50. PubMed ID: 15531106
[TBL] [Abstract][Full Text] [Related]
37. Charged bipolar suramin derivatives induce aggregation of the prion protein at the cell surface and inhibit PrPSc replication.
Nunziante M; Kehler C; Maas E; Kassack MU; Groschup M; Schätzl HM
J Cell Sci; 2005 Nov; 118(Pt 21):4959-73. PubMed ID: 16219680
[TBL] [Abstract][Full Text] [Related]
38. Binding of disease-associated prion protein to plasminogen.
Fischer MB; Roeckl C; Parizek P; Schwarz HP; Aguzzi A
Nature; 2000 Nov; 408(6811):479-83. PubMed ID: 11100730
[TBL] [Abstract][Full Text] [Related]
39. Differential solubility of prions is associated in manifold phenotypes.
Kuczius T; Karch H; Groschup MH
Mol Cell Neurosci; 2009 Nov; 42(3):226-33. PubMed ID: 19607920
[TBL] [Abstract][Full Text] [Related]
40. Cellular prion protein localizes to the nucleus of endocrine and neuronal cells and interacts with structural chromatin components.
Strom A; Wang GS; Picketts DJ; Reimer R; Stuke AW; Scott FW
Eur J Cell Biol; 2011 May; 90(5):414-9. PubMed ID: 21277044
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
